BLFS
BioLife Solutions, Inc.
Medical Instruments & Supplies · Healthcare · United States
38.61
close · 2026-10-05
value
11
cheaper than peers11
quality
86
stronger fundamentals86
ranked against
Medical Instruments & Supplies
value
quality
33 peerswide variation
caveat margins at their own peak
Value inputs
| measure | company | vs peers |
| earnings yield, latest year | -0.3% | 56 |
| earnings yield, 1 year ago | -1.3% | 44 |
| price to book | 4.49× | 33 |
| cash flow yield, 2 years ago | -1.1% | 31 |
| cash flow yield, 3 years ago | -1.1% | 31 |
| cash flow yield, 1 year ago | 0.3% | 19 |
| earnings yield, 3 years ago | -9.4% | 19 |
| forward P/E | 117.00× | 9 |
| price to sales | 15.88× | 8 |
| cash flow yield, latest year | 0.0% | 6 |
| earnings yield, 2 years ago | -4.4% | 6 |
| EV to EBITDA | 236.00× | 2 |
12 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 3.7% | 88 |
| revenue growth | 21.5% | 83 |
| return on equity | 12.8% | 73 |
| operating margin | 6.0% | 32 |
4 of 4 measures available
Facts
| market cap | $2B |
| free cash flow | $4.7M |
| employees | 155 |
| first trade | 1989-11-22 |
| next earnings | 2026-08-06 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.10 | -0.44 | -1.55 | -3.29 |
| free cash flow | $416,000 | $4.9M | -$18.9M | -$18.9M |
| net income | -$4.6M | -$20.2M | -$68.0M | -$139.8M |
| revenue | $96.2M | $74.6M | $68.0M | $76.2M |
| unusual items | $0 | -$4.1M | $7.3M | $5.5M |